We focus on profitable and sustainable company growth
Friedrich von Rechteren, part of the ulrich medical management team since July 2024, has been CEO and Chairman of the Management Board since June 1, 2025. He succeeds Klaus Kiesel, who played a key role in shaping ulrich medical for over 30 years and successfully developed it over decades. Until his departure at the end of 2025, Klaus Kiesel will continue to accompany us as Co-CEO and support key strategic projects.
Christoph Ulrich, Managing Partner and great-grandson of the company founder, will also remain on the Management Board. With the early handover to Friedrich von Rechteren, we are setting the course for forward-looking and sustainable further development of the corporate group.
Responsibility for specialist areas
Due to the steady, often above-average growth that we have regularly achieved in recent years, two Authorized Officers were added to the Executive Board in 2018: since then, Sven Erdmann has been in charge of technology and regulation, while Steffen Kölsch is in charge of operations and quality management.
Cornelia Schweizer has been a member of the Executive Board and Authorized Officer of the company as Head of Sales and Marketing since 2021. In 2023, Steffen May completed the management team as Commercial Director.
